|
Swiss Medical Care introduces a New Interactive Multi-Media Console 3D to its CT Exprés III™
(November 28, 2008)
Swiss Medical Care (SMC), a Swiss company focused on innovative solutions for diagnostic imaging/contrast media delivery is proud to introduce the first interactive multi-media Console 3D for CT Scan injectors compatible with its line of CT Exprés III™ products. The CT Exprés 3D will be introduced at the RSNA in Chicago starting November 30th, 2008.
"The introduction of the CT Exprés 3D™ represents a significant step in our development objectives to better serve the needs of the Radiology community. With this new multimedia interface, our syringe-less multidose injector becomes even easier to use and offers new opportunities for IT, interfacing, communication and servicing. It also is a basis for new injection modalities which will become progressively available in the course of the coming year, as well as a platform for continuous innovations. After the success of the CT Exprés III in Europe, we believe the CT Exprés 3D™ will result in an unparalleled option for radiology teams and institutions in every country using advanced imaging techniques " says Frédéric Neftel, MD, President & CEO of Swiss Medical Care.
About CT Exprés 3D™:
CT Exprés 3D™ is adding a novel multimedia interface to the three line syringe-less injector which is able to perform Saline flush directly from a bag in addition to the injection of Contrast Media from two up to 1000 mL bottles. In addition, the CT Exprés 3D™ offers multiple programming capabilities, for both Angiographic CT and conventional CT procedures, making the best use of Saline procedure before, in between and after each Contrast Media phase.
About SMC – Swiss Medical Care:
Swiss Medical Care SA (SMC) was founded in 2003, when Debiotech SA and a Group of Private Investors created a company specialising in sales and marketing of innovative products in the field of Diagnostic Imaging. Swiss Medical Care’s product portfolio: "CT Exprés™ " is the first innovative solution targeted at better satisfying customer’s needs, cost containment considerations and safety concerns while enabling multi-dosing and potential increase of patient throughput.
<<Back |
